Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T12:16:52.928Z Has data issue: false hasContentIssue false
  • English
  • Français

Quetiapina en ancianos con parkinsonismo y psicosis

Published online by Cambridge University Press:  12 May 2020

H. H. Wijnen ,
F.M.M.A. van der Heijden ,
F. M. E. van Schendel ,
S. Tuinier  and
W. M. A. Verhoeven
H. H. Wijnen
Affiliation:
Instituto Vincent van Gogh para Psiquiatría, Postbus 5, 5800 AA Venray, Países Bajos
F.M.M.A. van der Heijden
Affiliation:
Instituto Vincent van Gogh para Psiquiatría, Postbus 5, 5800 AA Venray, Países Bajos
F. M. E. van Schendel
Affiliation:
Instituto Vincent van Gogh para Psiquiatría, Postbus 5, 5800 AA Venray, Países Bajos
S. Tuinier
Affiliation:
Instituto Vincent van Gogh para Psiquiatría, Postbus 5, 5800 AA Venray, Países Bajos
W. M. A. Verhoeven
Affiliation:
Instituto Vincent van Gogh para Psiquiatría, Postbus 5, 5800 AA Venray, Países Bajos Departamento de Psiquiatr쟬 Centro M裩co de la Universidad Erasmus, Rotterdam, Países Bajos
Get access

Resumen

En el presente estudio prospectivo al descubierto se investigaron los efectos de la quetiapina en dos pacientes ancianos con parkinsonismo y psicosis. El tratamiento indujo un acusado efecto antipsicótico que coincidió con una mejoría del funcionamiento motor general. Estos hallazgos apoyan la idea de que la quetiapina puede servir preferencialmente en los ancianos con enfermedad de Parkinson y síntomas psicóticos.

Keywords

quetiapinaancianospsicosisparkinsonismo
Type
Informe Clínico
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 1 , February 2004 , pp. 61 - 63
Copyright
Copyright © European Psychiatric Association 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Targum, SD, Abbott, JL. Efficacy of quetiapine in Parkinson’s patients with psychosis. J Clin Psychopharmacol 2000;20:54–60.CrossRefGoogle ScholarPubMed
Friedman, JH, Factor, SA. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson’s disease. Mov Disord 2000;15:201–11.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Fernandez, HH, Trieschmann, ME, Burke, MA, Friedman, JH. Quetiapine for psychosis in Parkinson’s disease versus dementia with Lewy bodies. J Clin Psychiatry 2002;63:513–5.CrossRefGoogle ScholarPubMed
Walker, Z, Grace, J, Overshot, R, Satarasinghe, S, Swan, A, Katona, CLE, et al.Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999;14:459–66.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Hwang, JP, Yang, CH, Yu, HC, Chang, JW, Cheng, CY, Tsai, SJ. The efficacy and safety of risperidone for the treatment of geriatric psychosis. J Clin Psychopharmacol 2001;21:583–7.CrossRefGoogle ScholarPubMed
Arnt, J, Skarsfeldt, T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 1998;18:63–101.CrossRefGoogle Scholar
Goldsteins, JM. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today 1999;35:193–210.CrossRefGoogle Scholar
Van der Heijden, FMMA, Verhoeven, WMA, Fekkes, D, Sijben, AES, Tuinier, S. Quetiapine in relapsing schizophrenia: clinical efficacy and the effect on monoaminergic parameters. Acta Neuropsychiatr 2003;15:133–9.CrossRefGoogle ScholarPubMed
Boumann, WP, Pinner, G. Use of atypical antipsychotic drugs in oíd age psychiatry. Adv Psychiatric Treatment 2002;8:49–58.CrossRefGoogle Scholar